Combination Lymphoma Immunotherapy Using Checkpoint Blockade and Intratumoral Virus-like Particles Containing CpG TLR9 Agonist

Overview of attention for article published in Blood, December 2016

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (83rd percentile)
High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

patent: 5 patents

Readers on

mendeley: 9 Mendeley

So far, Altmetric has seen 5 patents that reference this research output.

Compositions and methods for tumor immunotherapy

Grant US-12246031-B2

United States of America

11 Mar 2025

Packaging oligonucleotides into virus-like particles

Grant US-12084655-B2

United States of America

10 Sep 2024

COMBINATION TUMOR IMMUNOTHERAPY

Application EP-3835312-A1

European Patent Office

16 Jun 2021

COMBINATION TUMOR IMMUNOTHERAPY

Application EP-3240801-A4

European Patent Office

25 Jul 2018

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 1 additional patents.